CIK 0001231457
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
GENELUX Corp
Sign in to watch- Ticker
- GNLX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 805-267-9889
- Business address
- 2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE, CA, 91361
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $155,693
- in 6 filings
Net −$155,693. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-17 | Yu Tony VP, Clinical Trial Operations | Grant or award | +9,000 | 159,000 | ||
| 2023-02-17 | Cappello Joseph VP, Pharmaceutical Development | Grant or award | +9,000 | 9,000 | ||
| 2023-01-30 | Szalay Aladar 10% owner | Conversion | +500,000 | 2,258,760 | ||
| 2023-01-30 | Szalay Aladar 10% owner | Conversion | +500,000 | 550,000 | ||
| 2023-01-30 | Szalay Aladar 10% owner | Conversion · Series A Preferred Stock | −1,500,000 | 0 | ||
| 2023-01-30 | Szalay Aladar 10% owner | Conversion · Series A Preferred Stock | −1,500,000 | 0 | ||
| 2023-01-30 | Thomas John Director | Conversion | +470,000 | 470,000 | ||
| 2023-01-30 | Thomas John Director | Conversion · Series A Preferred Stock | −1,410,000 | 0 | ||
| 2023-01-30 | Woodward Gabe Director | Conversion | +5,378 | 5,378 | ||
| 2023-01-30 | Woodward Gabe Director | Conversion | +3,186 | 3,186 | ||
| 2023-01-30 | Woodward Gabe Director | Conversion | +2,798 | 2,798 | ||
| 2023-01-30 | Woodward Gabe Director | Conversion · Series I Preferred Stock | −13,000 | 0 | ||
| 2023-01-30 | Woodward Gabe Director | Conversion · Series J Preferred Stock | −7,000 | 0 | ||
| 2023-01-30 | Woodward Gabe Director | Conversion · Series K Preferred Stock | −6,000 | 0 | ||
| 2023-01-26 | Zhang Qian Associate VP, Research | Purchase | +200 | $6.25 | $1K | 200 |
Page 16 of 16 · 315 trades